Use of ATG in Treatment of Steroid-resistant Rejection
Overview
Authors
Affiliations
Anti-thymocyte globulin for treatment of T-cell-mediated allograft rejection.
Acharya S, Lama S, Kanigicherla D World J Transplant. 2024; 13(6):299-308.
PMID: 38174145 PMC: 10758678. DOI: 10.5500/wjt.v13.i6.299.
Antithymocyte treatment of steroid-resistant acute rejection in renal transplantation.
Shenoy M, Roberts D, Plant N, Lewis M, Webb N Pediatr Nephrol. 2011; 26(5):815-8.
PMID: 21340611 DOI: 10.1007/s00467-011-1798-9.
Gaber A, Monaco A, Russell J, Lebranchu Y, Mohty M Drugs. 2010; 70(6):691-732.
PMID: 20394456 DOI: 10.2165/11315940-000000000-00000.
Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help.
Heidt S, Roelen D, Eijsink C, Eikmans M, van Kooten C, Claas F Clin Exp Immunol. 2009; 159(2):199-207.
PMID: 19922499 PMC: 2810388. DOI: 10.1111/j.1365-2249.2009.04051.x.
Monitoring antithymocyte globulin in renal transplantation.
Clark K Ann R Coll Surg Engl. 1996; 78(6):536-40.
PMID: 8943640 PMC: 2502841.